Back to search
FDAFDA · Food and drugs·Recall number D-0279-2015

5% Dextrose Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7922-09.

Published December 3, 2014 · Recall initiated: October 14, 2014

Summary

FDA records drug Class II recall D-0279-2015, published December 3, 2014 and initiated October 14, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 301,560 bags; Lot: Lot # 33-094-JT; Exp. 09/15 Lot # 35-028-JT; Exp. 11/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide, Puerto Rico, and U.S. Virgin Islands.
Lot
Lot # 33-094-JT; Exp. 09/15 Lot # 35-028-JT; Exp. 11/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 5% Dextrose Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7922-09. recalled?

Yes. FDA published recall D-0279-2015 on December 3, 2014. Reported hazard: Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

What should I do if I have this product?

Voluntary: Firm initiated · Letter